AstraZeneca said to have explored Bristol Myers merger

WorldPing

Bristol Myers Squibb, which has a $133 billion market capitalization, could provide AstraZeneca with a bigger foothold in the US market.

Related news

CNBC World•

AstraZeneca slides after reports of Bristol Myers merger talks leave analysts 'perplexed'

The companies have discussed a potential merger over several months, reports say.

Brief by WorldPing · Original reporting by CNBC World

WorldPing

STAT•

STAT+: Pharmalittle: We’re reading about AstraZeneca-Bristol merger talks, a revised 340B plan, and more

AstraZeneca stock fell as investors balked at reports of merger talks with Bristol Myers Squibb about forming one of ​the world's biggest drugmakers…

Brief by WorldPing · Original reporting by STAT

WorldPing

The Guardian•

AstraZeneca holds talks with US cancer drug developer in $400bn merger

Bristol Myers Squibb tie-up would be one of biggest-ever pharma deals and create world’s fourth-largest drugmaker Business live – latest updates Britain’s biggest drugmaker, AstraZeneca, is understood to be in discussions to take over its US rival Br…

Brief by WorldPing · Original reporting by The Guardian

WorldPing

STAT•

STAT+: Is there a pharma mega-merger in the making?

Moderna's imminent FDA vaccine decision, TCGX launches $400M Asia biotech fund, and more biotech news…

Brief by WorldPing · Original reporting by STAT